Empagliflozin

Key points

• Classed as an SGLT2 inhibitor, it lowers blood sugar by blocking a kidney protein that would otherwise reabsorb glucose back into the blood.
• Used alongside diet and exercise for type 2 diabetes, and requires known kidney function beforehand since it depends on renal filtration.
• Because it works by increasing urination, it can raise the chance of genital infections or mild dehydration if fluid intake is not maintained.

What is Empagliflozin?

Empagliflozin is an SGLT2 inhibitor used to support better glycaemic control in adults. By targeting specific pathways in the kidneys, it allows for more efficient glucose regulation throughout the day. It is often integrated into broader Diabetes Management strategies to lower overall blood sugar levels.

What Empagliflozin is used for

Physicians primarily use this medication for individuals living with Type 2 Diabetes. It works as an adjunct to diet and exercise to achieve target glucose ranges.

How does Empagliflozin work?

The medication works by blocking a specific protein in the kidneys that typically reabsorbs sugar back into the bloodstream. By preventing this reabsorption, excess glucose is instead excreted through the urine. This process lowers blood sugar levels directly and contributes to better metabolic stability.

Empagliflozin brands and forms

Glyxambi is available as a film-coated tablet. Brand-name and generic formulations are designed to offer consistent delivery, though preferences for specific manufacturers often vary based on individual treatment plans.

Safety overview for Empagliflozin

What to check before using this medicine

Prior to initiating treatment, ensure your current renal function is known, as this medication relies on kidney filtration. Discuss any history of urinary tract infections or low blood pressure with your clinician.

Possible reactions and tolerability

Common responses include increased urination frequency, which is expected given the mechanism of action. Some individuals may experience genital infections or signs of volume depletion. Monitoring hydration status is a standard consideration for those starting this treatment.

Interactions and health factors

Combining with other blood sugar regulators may require dose adjustments to avoid unexpected drops in glucose. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.

Further reading

• Empagliflozin: MedlinePlus Drug Information
• Empagliflozin 10 mg film-coated tablets
• Empagliflozin - Uses, How it Works and Side Effects - Diabetes UK